Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
ACS Med Chem Lett ; 14(3): 297-304, 2023 Mar 09.
Artículo en Inglés | MEDLINE | ID: mdl-36923916

RESUMEN

Selective CDK2 inhibitors have the potential to provide effective therapeutics for CDK2-dependent cancers and for combating drug resistance due to high cyclin E1 (CCNE1) expression intrinsically or CCNE1 amplification induced by treatment of CDK4/6 inhibitors. Generative models that take advantage of deep learning are being increasingly integrated into early drug discovery for hit identification and lead optimization. Here we report the discovery of a highly potent and selective macrocyclic CDK2 inhibitor QR-6401 (23) accelerated by the application of generative models and structure-based drug design (SBDD). QR-6401 (23) demonstrated robust antitumor efficacy in an OVCAR3 ovarian cancer xenograft model via oral administration.

2.
Carbohydr Res ; 341(2): 191-7, 2006 Feb 06.
Artículo en Inglés | MEDLINE | ID: mdl-16332360

RESUMEN

A pentasaccharide, beta-D-Man-(1-->2)-[beta-D-GlcNAc-(1-->4)]-alpha-L-Rha-(1-->4)-alpha-L-Rha-(1-->4)-alpha-L-Rha-1-OC8H17, representing the repeating unit of latosillan, was convergently synthesized from the building blocks, ethyl 2,3-O-isopropylidene-1-thio-alpha-l-rhamnopyranoside, 2-O-acetyl-3,4,6-tri-O-benzyl-beta-d-glucopyranosyl trichloroacetimidate, and 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-beta-d-glucopyranosyl trichloroacetimidate under standard glycosylation conditions. The target pentasaccharide showed acceptable differentiation-inducing activity on HL-60 cell lines at the dosages of 10-50 microg/mL.


Asunto(s)
Oligosacáridos/síntesis química , Animales , Diferenciación Celular/efectos de los fármacos , Línea Celular Tumoral , Glucosa/análogos & derivados , Glucosa/química , Células HL-60 , Humanos , Ratones , Oligosacáridos/farmacología , Polisacáridos/síntesis química , Polisacáridos/farmacología , Ramnosa/análogos & derivados , Ramnosa/química
3.
Carbohydr Res ; 339(12): 2083-90, 2004 Aug 23.
Artículo en Inglés | MEDLINE | ID: mdl-15280053

RESUMEN

Octyl 2,3-di-O-sulfo-alpha-L-fucopyranosyl-(1-->3)-2-O-sulfo-alpha-L-fucopyranosyl-(1-->4)-2,3-di-O-sulfo-alpha-L-fucopyranosyl-(1-->3)-2-O-sulfo-alpha-L-fucopyranosyl-(1-->4)-2,3-di-O-sulfo-beta-L-fucopyranoside, a fucosyl pentasaccharide with a regular structure resembling the repeating unit of a natural sulfated fucan, was chemically synthesized using a convergent '2+3' strategy. Regioselective 3-O-silylation of beta-thiofucopyranoside and AgOTf-catalyzed glycosylation of the protected glycosyl trichloroacetimidate facilitated a one-pot trisaccharide synthesis. The synthesized target compound showed good antitumor activity in vivo, and promising anticoagulant activity in vitro.


Asunto(s)
Anticoagulantes/síntesis química , Anticoagulantes/farmacología , Antineoplásicos/síntesis química , Antineoplásicos/farmacología , Oligosacáridos/síntesis química , Oligosacáridos/farmacología , Animales , Anticoagulantes/química , Antineoplásicos/química , Conformación de Carbohidratos , Secuencia de Carbohidratos , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Ratones , Datos de Secuencia Molecular , Oligosacáridos/química , Estereoisomerismo
4.
Carbohydr Res ; 339(4): 867-72, 2004 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-14980830

RESUMEN

An efficient method for the regioselective 3-O-silylation of beta-thiofucopyranoside was disclosed. Based on this discovery, we described a high-yielding strategy for the synthesis of the natural core structure of L-fucan and its fully sulfated derivative. The bioassay suggested that octyl 2,3,4-tri-O-sulfo-alpha-L-fucopyranosyl-(1-->3)-2,4-di-O-sulfo-alpha-L-fucopyranosyl-(1-->3)-2,4-di-O-sulfo-alpha-L-fucopyranosyl-(1-->3)-2,4-di-O-sulfo-beta-L-fucopyranoside presented better antitumor activities than that of the free tetramer based on Sarcoma 180 cells and Lewis lung carcinoma model studies.


Asunto(s)
Antineoplásicos/síntesis química , Antineoplásicos/farmacología , Glicósidos/síntesis química , Glicósidos/farmacología , Oligosacáridos/síntesis química , Oligosacáridos/farmacología , Ésteres del Ácido Sulfúrico/síntesis química , Ésteres del Ácido Sulfúrico/farmacología , Animales , Antineoplásicos/química , Secuencia de Carbohidratos , Línea Celular Tumoral , Glicósidos/química , Ratones , Datos de Secuencia Molecular , Oligosacáridos/química , Ésteres del Ácido Sulfúrico/química , Ensayos Antitumor por Modelo de Xenoinjerto
5.
Org Lett ; 5(20): 3627-30, 2003 Oct 02.
Artículo en Inglés | MEDLINE | ID: mdl-14507189

RESUMEN

[reaction: see text] A new class of glycosyl donors having unprotected 2- and 2,4-hydroxyl groups were investigated under the standard glycosylation conditions. This approach was shown to be generally effective for the synthesis of alkyl and steroidal glycosides. A natural saponin, containing 2,4-branched oligosaccharide, was prepared in 35% overall yield in four straightforward sequential reactions by taking advantage of these partially protected donors.


Asunto(s)
Saponinas/síntesis química , Glicosilación , Oligosacáridos/síntesis química , Estereoisomerismo
6.
Carbohydr Res ; 338(12): 1313-8, 2003 Jun 16.
Artículo en Inglés | MEDLINE | ID: mdl-12791285

RESUMEN

Biantennary beta-D-(1-->6) glucosamine hexa-, octa-, and dodecaoligosaccharide derivatives were synthesized convergently using isopropyl thioglycosides as donors in NIS/TMSOTf-catalyzed glycosylation.


Asunto(s)
Glucosamina/síntesis química , Oligosacáridos/síntesis química , Secuencia de Carbohidratos , Catálisis , Glucosamina/química , Glicosilación , Datos de Secuencia Molecular , Oligosacáridos/química , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...